Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

L. D. Lilien, G. Srinivasan, T. F. Yeh, R. S. Pildes

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)

摘要

The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

原文英語
頁(從 - 到)73-77
頁數5
期刊Pediatric Pharmacology
5
發行號1
出版狀態已發佈 - 一月 1 1985
對外發佈Yes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

指紋 深入研究「Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus」主題。共同形成了獨特的指紋。

  • 引用此